National Research Institute

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Familial hypercholesterolaemia1 trial
• High blood pressure1 trial
• Lung cancer1 trial

Phase

• Phase 21 trial
• Phase 31 trial

Status

• Active, not recruiting3 trials

Lead sponsor

• Novartis Pharmaceuticals2 trials
• Guardant Health, Inc.1 trial

Running trials

• Active, not recruiting

  A Study to Identify an Optimal Dose of QCZ484 in Mild to Moderate Hypertensive Patients

  NCT06857955· Phase 2· Novartis Pharmaceuticals· Source

• Active, not recruiting

  Screening for High Frequency Malignant Disease

  NCT05117840· Guardant Health, Inc.· Source

• Active, not recruiting

  Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease

  NCT05030428· Phase 3· Novartis Pharmaceuticals· Source